Psyence Biomedical Ltd(PBM),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

PBM Psyence Biomedical Ltd

Closed 01-08 16:00:00 EST

1.84

-0.07

-3.66%

盘后1.84

+0.000.00%

19:57 EST

High1.98	Low1.78	Vol205.05K
Open1.91	D1 Closing1.91	Amplitude10.47%
Mkt Cap6.31M	Tradable Cap6.06M	Total Shares3.43M
T/O382.42K	T/O Rate6.22%	Tradable Shares3.29M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"PBM","market":"US","secType":"STK","nameCN":"Psyence Biomedical Ltd","latestPrice":1.84,"timestamp":1736370000000,"preClose":1.91,"halted":0,"volume":205050,"hourTrading":{"tag":"盘后","latestPrice":1.84,"preClose":1.84,"latestTime":"19:57 EST","volume":5346,"amount":9617.7869,"timestamp":1736384244349},"delay":0,"floatShares":3294820,"shares":3427128,"eps":-286.5411,"marketStatus":"Closed","change":-0.07,"latestTime":"01-08 16:00:00 EST","open":1.91,"high":1.98,"low":1.78,"amount":382420.936155,"amplitude":0.104712,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-286.5411,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Market Trading","tradingStatus":1,"beginTime":1736499600000},"marketStatusCode":5,"adr":0,"exchange":"NASDAQ","adjPreClose":1.91,"preHourTrading":{"tag":"盘前","latestPrice":1.96,"preClose":1.91,"latestTime":"09:28 EST","volume":2257,"amount":4395.9329445,"timestamp":1736346500282},"postHourTrading":{"tag":"盘后","latestPrice":1.84,"preClose":1.84,"latestTime":"19:57 EST","volume":5346,"amount":9617.7869,"timestamp":1736384244349},"volumeRatio":1.007745},"requestUrl":"/m/hq/s/PBM/tweets","defaultTab":"tweets","newsList":[{"id":"2501347787","title":"Headline Risks Affecting Healthcare Tech & Distribution Sector Will Likely Continue in 2025: BofA Analyst","url":"https://stock-news.laohu8.com/highlight/detail?id=2501347787","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501347787?lang=en_us&edition=fundamental","pubTime":"2025-01-08 01:03","pubTimestamp":1736269424,"startTime":"0","endTime":"0","summary":"BofA Securities predicts that headline risks affecting the Healthcare Tech & Distribution sector in 2024 will likely continue in 2025.Key areas of concern include pharmacy benefit managers , retail pharmacies, distributors, fertility benefits, and direct-to-consumer  pharmacies.While regulatory pressure on PBMs is expected to persist, the analyst believes this will mainly impact profit margins and growth rates rather than lead to major changes in the business model.Potential policy shifts under the next administration could involve adjustments to the Inflation Reduction Act, expanded access to health savings accounts , and increased support for fertility benefits.BofA upgraded Cardinal Health Inc.  from Neutral to Buy. The analyst notes Cardinal Health’s core pharmaceutical segment is growing faster than its competitors, with this trend expected to strengthen in the coming year.The company is benefiting from a unique advantage in its pharmacy benefit management  business, which could a","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/headline-risks-affecting-healthcare-tech-170344350.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0122379950.USD","LU1880398471.USD","PBM","LU0965509010.AUD","LU1023059063.AUD","LU1037948541.HKD","LU0106831901.USD","HCSG","LU0868494617.USD","LU0795875169.SGD","LU1548497426.USD","CAH","LU0072461881.USD","LU1061106388.HKD","LU2324357040.USD","BK4585","LU0006061336.USD","LU2468319806.SGD","LU1267930227.SGD","LU2089984988.USD","LU1430594728.SGD","LU1934455194.USD","BK4137","LU1267930813.SGD","LU1571399168.USD","LU0320765646.SGD","SG9999001440.SGD","LU0912757837.SGD","LU0742534661.SGD","LU2347655156.SGD","LU1037948897.HKD","LU0310800965.SGD","LU1989772923.USD","LU0861579265.USD","LU1880398554.USD","LU2357305700.SGD","BK4175","LU2112291526.USD","MCK","LU0225283273.USD","LU0006306889.USD","LU0048573561.USD","LU0314104364.USD","LU0889566641.SGD","LU2028103732.USD","LU2089283258.USD","HSIC","LU0310799852.SGD","LU0942090050.USD","LU0971096721.USD"],"gpt_icon":0},{"id":"2495270541","title":"Psyence Biomedical Closes $2 Million Private Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2495270541","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2495270541?lang=en_us&edition=fundamental","pubTime":"2024-12-30 21:03","pubTimestamp":1735563807,"startTime":"0","endTime":"0","summary":"Psyence Biomedical  said late Friday it has completed its private placement for gross proceeds of $2 million.The company offered 1 million common shares or pre-funded warrants, series A warrants to purchase up to 1 million shares, and short-term series B warrants to purchase up to 1 million shares at a purchase price of $2 per share or per pre-funded warrant and accompanying series A and B warrants.The warrants have an exercise price of $2 per share and are exercisable immediately upon issuance.Proceeds from the offering are expected to be used for general corporate purposes, the company said.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PBM","BK4139"],"gpt_icon":0},{"id":"2495514878","title":"Drug Middlemen Got Spared By Trump and Musk -- Heard on the Street -- WSJ","url":"https://stock-news.laohu8.com/highlight/detail?id=2495514878","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2495514878?lang=en_us&edition=fundamental","pubTime":"2024-12-30 18:30","pubTimestamp":1735554600,"startTime":"0","endTime":"0","summary":"Tucked into the bipartisan budget deal that President-elect Donald Trump's allies torpedoed earlier this month was a rare and significant attempt to reform the mechanics of America's drug-pricing system.Americans are broadly aware of how big pharma profits from high drug prices, but few understand the market distortions introduced by pharmacy benefit management  companies that negotiate prices on behalf of employers, insurers and government programs.The failed budget bill included provisions that would have addressed some of the misaligned incentives within the PBM business model. But health conglomerates Cigna, CVS Health and UnitedHealth Group, which own the three largest PBMs, caught a break when Elon Musk, Vivek Ramaswamy and other Trump allies began agitating against the bill. This set off a frantic effort in Washington to pass a stripped-down version of the legislation that no longer contained many extraneous measures, including the PBM changes.PBMs, once obscure entities in the ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2125154778.USD","LU1061106388.HKD","LU0234572021.USD","IE00B7KXQ091.USD","LU0256863811.USD","LU0079474960.USD","CVS","IE00B2B36J28.USD","LU0029864427.USD","LU1003077747.HKD","LU2279689827.SGD","SGXZ31699556.SGD","LU1267930490.SGD","PBM","LU0211327993.USD","LU1720051017.SGD","LU0053666078.USD","LU2125154935.USD","LU0061475181.USD","LU1057294990.SGD","LU1854103824.USD","LU0965508806.USD","LU2112291526.USD","LU0208291251.USD","LU1023059063.AUD","LU2491050154.USD","LU0417517546.SGD","LU0795875086.SGD","LU2324357040.USD","IE00B7SZLL34.SGD","LU0738911758.USD","LU2087625088.SGD","LU0070302665.USD","LU2491050071.SGD","LU0251132253.USD","LU1988902786.USD","UNH","LU0868494617.USD","IE0004445015.USD","CI","LU1261432733.SGD","LU0965509010.AUD","LU2244417387.USD","LU1778281490.HKD","SG9999001176.SGD","LU1571399168.USD","LU2362541273.HKD","LU0266013472.USD","LU0320765059.SGD"],"gpt_icon":1},{"id":"2495512795","title":"Is UnitedHealth Group Stock a Buy?","url":"https://stock-news.laohu8.com/highlight/detail?id=2495512795","media":"Motley Fool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2495512795?lang=en_us&edition=fundamental","pubTime":"2024-12-30 17:53","pubTimestamp":1735552380,"startTime":"0","endTime":"0","summary":"Shares of what may be America's most powerful healthcare company have declined due to controversy and regulatory threats.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com/investing/2024/12/30/is-unitedhealth-group-stock-a-buy/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"fool_stock","symbols":["LU2491050154.USD","LU0976567544.SGD","LU2361044865.SGD","SG9999001176.USD","LU1778281490.HKD","LU0256863811.USD","IE00B1BXHZ80.USD","LU2362541513.USD","IE00BFTCPJ56.SGD","LU1548497426.USD","LU1496350502.SGD","LU1989771016.USD","UNH","LU1791710400.SGD","LU0787776722.HKD","LU0203345920.USD","LU2461242641.AUD","LU0345770993.USD","LU2236285917.USD","LU2111349929.HKD","LU0211326839.USD","LU0107464264.USD","LU0353189680.USD","LU1074936037.SGD","LU2089283258.USD","LU0077335932.USD","LU1084165304.USD","LU1791710582.SGD","IE00B894F039.SGD","IE00B4JS1V06.HKD","IE00BJJMRY28.SGD","BK4154","LU0122379950.USD","LU1267930730.SGD","SG9999017495.SGD","LU0545039389.USD","LU2324357040.USD","SG9999002232.USD","TTM","LU1732800096.USD","LU1670628061.USD","LU1814569148.SGD","PBM","LU2089284900.SGD","LU1934455277.USD","LU1323610961.USD","LU2362540622.SGD"],"gpt_icon":1},{"id":"2495265023","title":"CVS Health Corporation (CVS): Among the Cheap Healthcare Stocks to Buy Heading Into 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2495265023","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2495265023?lang=en_us&edition=fundamental","pubTime":"2024-12-29 05:54","pubTimestamp":1735422886,"startTime":"0","endTime":"0","summary":"We recently compiled a list of the 12 Cheap Healthcare Stocks to Buy Heading into 2025.In this article, we are going to take a look at where CVS Health Corporation  stands against the other cheap healthcare stocks.The Resilience and Challenges of Global Healthcare Spending. Investing in healthcare equities is typically seen as protective during recessionary times. This is because, even in hard financial times, consumers usually do not reduce their usage of prescription drugs or other necessary healthcare services. National healthcare spending is expected to reach an estimated $4.8 trillion in 2023 and increase at a 5.6% annual pace between 2027 and 2032, according to the Centers for Medicare and Medicaid Services .Nevertheless, the U.S. spends over twice as much on healthcare as the OECD average, despite these difficulties, and the average results are poorer. This discrepancy emphasizes how ineffective and unsustainable the c","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cvs-health-corporation-cvs-among-215446414.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00BYQQ9H92.USD","LU2346227817.USD","LU0162691827.USD","BK4585","LU0061475181.USD","LU0127658192.USD","CVS","LU1316542783.SGD","LU2361044865.SGD","IE00B4JS1V06.HKD","LU0823434583.USD","HCSG","LU2764263203.CNY","LU1989772923.USD","LU2764263039.SGD","PBM","LU0289941410.SGD","SGXZ81514606.USD","LU0345769128.USD","LU0823421416.USD","LU0868494617.USD","LU1145028129.USD","LU2637428348.USD","LU1989764748.USD","LU0820561909.HKD","LU0820561818.USD","IE00BWXC8680.SGD","LU0957791311.USD","LU0823434740.USD","LU0072461881.USD","LU0889565833.HKD","MA","LU0708995401.HKD","LU2213496289.HKD","LU1699723380.USD","LU0056508442.USD","LU1718418525.SGD","LU0198837287.USD","LU0320765059.SGD","LU0061474705.USD","LU0256863811.USD","IE00BJJMRY28.SGD","LU1363072403.SGD","CMS","LU0006061336.USD","LU2317271919.USD","LU2361044949.HKD","LU0353189680.USD","LU0006306889.USD","LU0061474960.USD"],"gpt_icon":0},{"id":"2494358828","title":"Psyence Biomed Announces Closing of $2.0 Million Private Placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2494358828","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2494358828?lang=en_us&edition=fundamental","pubTime":"2024-12-28 05:05","pubTimestamp":1735333535,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241227:nTUA1FVJQG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","PBM"],"gpt_icon":0},{"id":"2494358817","title":"Press Release: Psyence Biomed Announces Closing of $2.0 Million Private Placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2494358817","media":"Dow Jones","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2494358817?lang=en_us&edition=fundamental","pubTime":"2024-12-28 05:05","pubTimestamp":1735333500,"startTime":"0","endTime":"0","summary":"NEW YORK, Dec. 27, 2024  -- Psyence Biomedical Ltd.   today announced that it has closed its previously announced private placement for the purchase and sale of an aggregate of 1,000,000 common shares , series A common warrants to purchase up to 1,000,000 common shares and short-term series B common warrants to purchase up to 1,000,000 common shares at a purchase price of $2.00 per common share  and accompanying series A common warrant and short-term series B common warrant. The series A common warrants and short-term series B common warrants have an exercise price of $2.00 per share and are exercisable immediately upon issuance. The series A common warrants expire five years from the date of issuance and the short-term series B common warrants expire two years from the date of issuance.Psyence Biomedical Ltd.  is the world's first life science biotechnology company developing nature-derived  psilocybin-based psychedelic medicines to be listed on Nasdaq. Psyence is initially working to","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NQmain","PBM"],"gpt_icon":0},{"id":"2493767468","title":"Psyence Biomedical Regains Nasdaq Compliance for Continued Listing","url":"https://stock-news.laohu8.com/highlight/detail?id=2493767468","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493767468?lang=en_us&edition=fundamental","pubTime":"2024-12-24 00:17","pubTimestamp":1734970634,"startTime":"0","endTime":"0","summary":"Psyence Biomedical  said Monday it received a Nasdaq notification that the firm has regained compliance with all applicable Nasdaq listing requirements, including minimum market value and stockholders' equity requirement.\"With Nasdaq compliance, a debt free balance sheet and a cash position of $5.6 million, the company is well positioned to execute its business plan and clinical trial, for which patient screening has commenced,\" Psyence said.Price: 2.37, Change: -0.81, Percent Change: -25.47","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00BKPKM429.USD","IE00B3QW5Z07.USD","TSYW.SI","PSQ","LU2095319765.USD","NDAQ","PBM","USJW.SI","USAW.SI","NVIW.SI","QID","LU2210150020.SGD","TQQQ","BK4139","SQQQ","MNQmain","NQmain","QLD","IE00BGHQF748.EUR","BK4588","LU2210149790.SGD","BK4112",".IXIC","IE00B64PRP62.GBP","BK4585"],"gpt_icon":1},{"id":"2493750166","title":"Psyence Biomedical Expects to Raise $2 Million From Private Placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2493750166","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493750166?lang=en_us&edition=fundamental","pubTime":"2024-12-23 21:40","pubTimestamp":1734961235,"startTime":"0","endTime":"0","summary":"Psyence Biomedical  said Monday it has agreed to a private placement of 1 million common shares or pre-funded warrants, along with accompanying series A and series B warrants, priced at $2 each for expected gross proceeds of $2 million.The company said the series A warrants expire in five years, while the series B warrants expire in two years. Both warrants, exercisable immediately after issuance, will have an exercise price of $2. it added.Net proceeds from the offering, slated to close around Tuesday, will be used for working capital and general purposes, Psyence said.Shares of the company were down more than 15% in recent Monday premarket activity.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","PBM"],"gpt_icon":0},{"id":"2493757921","title":"Psyence Biomedical prices 1M shares at $2.00 in private placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2493757921","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493757921?lang=en_us&edition=fundamental","pubTime":"2024-12-23 21:15","pubTimestamp":1734959732,"startTime":"0","endTime":"0","summary":"Psyence Biomedical (PBM) has entered into definitive agreements for the purchase and sale of an aggregate of 1,000,000 common shares series A commo...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/psyence-biomedical-prices-1m-shares-at-2-00-in-private-placement?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/psyence-biomedical-prices-1m-shares-at-2-00-in-private-placement?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","PBM"],"gpt_icon":0},{"id":"2493875240","title":"Investors Look to Reverse Last Week's Slide as US Futures Mixed Monday Pre-Bell","url":"https://stock-news.laohu8.com/highlight/detail?id=2493875240","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493875240?lang=en_us&edition=fundamental","pubTime":"2024-12-23 21:08","pubTimestamp":1734959307,"startTime":"0","endTime":"0","summary":"US stock futures are mixed in Monday's premarket session as investors hope to reverse last week losses during the holiday-shortened week.The Dow Jones Industrial Average futures were down 0.2%, S&P 50","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PBM","BK4077","TRAW","IE00B7SZL793.SGD","ISBC","BK4007","DSGN","BK4211","IE00B19Z4B17.USD","BK4123","PHIO","BK4539","BK4505","RUM","BK4516","IE0031619046.USD","IE00B66KJ199.SGD","MG","BK4139"],"gpt_icon":1},{"id":"2493752304","title":"Press Release: Psyence Biomed Announces $2.0 Million Private Placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2493752304","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493752304?lang=en_us&edition=fundamental","pubTime":"2024-12-23 21:00","pubTimestamp":1734958800,"startTime":"0","endTime":"0","summary":"NEW YORK, Dec. 23, 2024  -- Psyence Biomedical Ltd.   today announced that it has entered into definitive agreements for the purchase and sale of an aggregate of 1,000,000 common shares , series A common warrants to purchase up to 1,000,000 common shares and short-term series B common warrants to purchase up to 1,000,000 common shares at a purchase price of $2.00 per common share  and accompanying series A common warrant and short-term series B common warrant in a private placement. The series A common warrants and short-term series B common warrants will have an exercise price of $2.00 per share and will be exercisable immediately upon issuance. The series A common warrants will expire five years from the date of issuance and the short-term series B common warrants will expire two years from the date of issuance. The private placement is expected to close on or about December 24, 2024, subject to the satisfaction of customary closing conditions.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NQmain","BK4139","PBM"],"gpt_icon":1},{"id":"2493752651","title":"Psyence Biomedical regains full compliance with Nasdaq requirements","url":"https://stock-news.laohu8.com/highlight/detail?id=2493752651","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493752651?lang=en_us&edition=fundamental","pubTime":"2024-12-23 20:45","pubTimestamp":1734957954,"startTime":"0","endTime":"0","summary":"Psyence Biomedical (PBM) announced that it has received notice from the Nasdaq Hearings panel that the Company has regained compliance with all app...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/psyence-biomedical-regains-full-compliance-with-nasdaq-requirements?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/psyence-biomedical-regains-full-compliance-with-nasdaq-requirements?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","NDAQ","BK4588","MNQmain","NQmain","SQQQ","IE00BKPKM429.USD","BK4139","LU2095319765.USD","IE00BGHQF748.EUR","LU2210150020.SGD","TSYW.SI","NVIW.SI","IE00B3QW5Z07.USD","LU2210149790.SGD","QID","IE00B64PRP62.GBP","PSQ","BK4112","QLD","PBM","TQQQ",".IXIC","USAW.SI","USJW.SI"],"gpt_icon":0},{"id":"2493751985","title":"Psyence Biomedical Regains Full Compliance With All Nasdaq Continued Listing Requirements","url":"https://stock-news.laohu8.com/highlight/detail?id=2493751985","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493751985?lang=en_us&edition=fundamental","pubTime":"2024-12-23 20:30","pubTimestamp":1734957001,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241223:nTUA4MBJH0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00BKPKM429.USD","NDAQ","BK4585","LU2210149790.SGD","LU2210150020.SGD","IE00BGHQF748.EUR","LU2095319765.USD","BK4112","PBM","BK4139","BK4588","IE00B64PRP62.GBP","IE00B3QW5Z07.USD"],"gpt_icon":0},{"id":"2493472212","title":"BRIEF-Psyence Biomedical Files Prospectus Relates To Potential Offer, Sale, From Time To Time 10.9 Million Common Shares By Selling Securityholders","url":"https://stock-news.laohu8.com/highlight/detail?id=2493472212","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493472212?lang=en_us&edition=fundamental","pubTime":"2024-12-21 05:53","pubTimestamp":1734731626,"startTime":"0","endTime":"0","summary":"BRIEF-Psyence Biomedical Files Prospectus Relates To Potential Offer, Sale, From Time To Time 10.9 Million Common Shares By Selling SecurityholdersDec 20 (Reuters) - Psyence Biomedical Ltd PBM.O:PSYEN","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241220:nFWN3NL1HO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PBM"],"gpt_icon":1},{"id":"2493747477","title":"Psyence Biomedical files to sell 10.9M shares of common stock for holders","url":"https://stock-news.laohu8.com/highlight/detail?id=2493747477","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493747477?lang=en_us&edition=fundamental","pubTime":"2024-12-21 05:30","pubTimestamp":1734730246,"startTime":"0","endTime":"0","summary":"16:27 EST Psyence Biomedical (PBM) files to sell 10.9M shares of common stock for holders Published first on TheFly – the ultimate source for real-...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/psyence-biomedical-files-to-sell-10-9m-shares-of-common-stock-for-holders?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/psyence-biomedical-files-to-sell-10-9m-shares-of-common-stock-for-holders?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","PBM"],"gpt_icon":0},{"id":"2493471223","title":"Psyence Biomedical Files Prospectus Relates to Potential Offer, Sale, From Time to Time 10.9 Mln Common Shares by Selling Securityholders","url":"https://stock-news.laohu8.com/highlight/detail?id=2493471223","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493471223?lang=en_us&edition=fundamental","pubTime":"2024-12-21 05:20","pubTimestamp":1734729606,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241220:nFWN3NL1HO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PBM","BK4139"],"gpt_icon":0},{"id":"2492448472","title":"Investors Await Key Inflation Data as US Futures Decline in Friday's Premarket","url":"https://stock-news.laohu8.com/highlight/detail?id=2492448472","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492448472?lang=en_us&edition=fundamental","pubTime":"2024-12-20 21:06","pubTimestamp":1734699963,"startTime":"0","endTime":"0","summary":"US stock futures were trending lower in Friday's premarket session as investors await key inflation data set for release later in the morning.The Dow Jones Industrial Average futures were down 0.62%, ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"0136878ef76de94ac274d4d3726d77de","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ISBC","CYN","BK4139","NVNI","PBM","MTEM","MYSZ","HYZN","BK4149","BK4211","BK4023"],"gpt_icon":1},{"id":"2492418148","title":"US Stocks To Open Lower As Traders Brace For 'Triple Witching' Hour: Analyst Says End Of The Year Recovery 'Would Not Surprise Anyone'","url":"https://stock-news.laohu8.com/highlight/detail?id=2492418148","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492418148?lang=en_us&edition=fundamental","pubTime":"2024-12-20 18:37","pubTimestamp":1734691077,"startTime":"0","endTime":"0","summary":"U.S. futures declined on Friday, ahead of the &#39;Triple Witching&#39; hour, which is expected to see $6.6 trillion options expire, for the quarter.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/24/12/42611748/us-stocks-to-open-lower-as-traders-brace-for-triple-witching-hour-analyst-says-end-of-the-year-recovery-would-not-surprise-anyone","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SPXU","WGO","BK4563","NVIW.SI",".IXIC","HUMA","BK4593","QID","NKE","PSQ","USAW.SI","BK4533","NQmain","PBM","SPY","QLD","LU0052756011.USD","BK4504","SQQQ","LU0786609619.USD","LU1267930227.SGD","MNQmain","TQQQ","FDX","BK4581","LU0251142724.SGD","VOO","BK4585","USJW.SI","SDS","TSYW.SI","SH","ESmain","QQQ","UPRO","LU1303367103.USD","IVV","LU2098885051.SGD",".SPX","LU1571399168.USD","LU0128525689.USD","BK4566","LU0742534661.SGD","CCL","OEX","SSO","OEF","BK4517","BK4099"],"gpt_icon":1},{"id":"2492848731","title":"Republicans spending package includes no PBM reform, Punchbowl says","url":"https://stock-news.laohu8.com/highlight/detail?id=2492848731","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492848731?lang=en_us&edition=fundamental","pubTime":"2024-12-20 05:40","pubTimestamp":1734644439,"startTime":"0","endTime":"0","summary":"Jake Sherman of Punchbowl News reports that House Republicans are eyeing a package to extend government funding for three months and suspend the de...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/republicans-spending-package-includes-no-pbm-reform-punchbowl-says?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/republicans-spending-package-includes-no-pbm-reform-punchbowl-says?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PBM","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.pacificbooker.bc.ca","stockEarnings":[{"period":"1week","weight":-0.0948},{"period":"1month","weight":-0.1941},{"period":"3month","weight":-0.7247},{"period":"6month","weight":-0.9228},{"period":"1year","weight":-0.9976},{"period":"ytd","weight":-0.0948}],"compareEarnings":[{"period":"1week","weight":0.0044},{"period":"1month","weight":-0.0316},{"period":"3month","weight":0.0199},{"period":"6month","weight":0.0578},{"period":"1year","weight":0.2403},{"period":"ytd","weight":0.0044}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Newcourt Acquisition Corp. is a blank check company, which engages in the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded on February 25, 2021 and is headquartered in Oakland, CA.","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.219683},{"month":2,"riseRate":0.666667,"avgChangeRate":-0.229033},{"month":3,"riseRate":1,"avgChangeRate":0.362272},{"month":4,"riseRate":0.666667,"avgChangeRate":-0.067007},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.053855},{"month":6,"riseRate":0.666667,"avgChangeRate":-0.193429},{"month":7,"riseRate":1,"avgChangeRate":0.326596},{"month":8,"riseRate":0.666667,"avgChangeRate":-0.094421},{"month":9,"riseRate":0.666667,"avgChangeRate":-0.251038},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.101551},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.109939},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.187578}],"exchange":"NASDAQ","name":"Psyence Biomedical Ltd","nameEN":"Psyence Biomedical Ltd"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.4","shortVersion":"4.29.4","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Psyence Biomedical Ltd(PBM),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Psyence Biomedical Ltd(PBM) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Psyence Biomedical Ltd,PBM,Psyence Biomedical Ltd股票,Psyence Biomedical Ltd股票老虎,Psyence Biomedical Ltd股票老虎国际,Psyence Biomedical Ltd行情,Psyence Biomedical Ltd股票行情,Psyence Biomedical Ltd股价,Psyence Biomedical Ltd股市,Psyence Biomedical Ltd股票价格,Psyence Biomedical Ltd股票交易,Psyence Biomedical Ltd股票购买,Psyence Biomedical Ltd股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Psyence Biomedical Ltd(PBM),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Psyence Biomedical Ltd(PBM) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction